Eris Lifesciences on the lookout for acquisitions of brands, product portfolios

The company shortlists therapy segments such as cardio, diabetes, vitamins, neuro, dermatology and women#39;s health for buyouts. COO says there are opportunities coming from multinationals and large domestic companies.

from Moneycontrol Business News https://ift.tt/3rPZVla